Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Hepatitis C virus research, and Organ Transplantation Techniques and Outcomes.
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
Role of sex in liver tumor occurrence and clinical outcomes: A comprehensive review
Efficacy of immunotherapy in hepatocellular carcinoma: Does liver disease etiology have a role?
Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management
Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation
Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
Clinical impact of sexual dimorphism in non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH)
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation
Influence of Hepatocellular Carcinoma on Platelet Aggregation in Cirrhosis
New Indications for Liver Transplantation
Recent Advances in the Management of Acute Variceal Hemorrhage
Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation
International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis
Invasive fungal infection before and after liver transplantation
Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice
Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics
Hepatitis C virus eradication with direct‐acting antiviral improves insulin resistance
Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study
Should Patients With NAFLD/NASH Be Surveyed for HCC?
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study
Management of bacterial infection in the liver transplant candidate
Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus–infected patients treated with direct‐acting antivirals
Use of N -acetylcysteine during liver procurement: A prospective randomized controlled study